TEVA (STOCKS)
Teva Pharmaceutical Industries Limited American Depositary Shares
$36.323400
-0.416600 (-1.13%)
Prev close: $36.740000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Generic
- CEO
- Richard Francis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $45,622.22M
- Employees
- 35,686
- P/E (TTM)
- 61.78
- P/B (TTM)
- 5.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.02 | $0.25 | -0.2316 | -92.05% |
|
Mar 2026 (Q1)
|
$0.53 | $0.49 | +0.0428 | +8.78% |
|
Dec 2025 (Q4)
|
$0.96 | $0.69 | +0.2671 | +38.55% |
|
Sep 2025 (Q3)
|
$0.78 | $0.67 | +0.1105 | +16.50% |
Financial Statements
| Revenues | $14.10B |
| Benefits Costs and Expenses | $11.98B |
| Cost Of Revenue | $8.23B |
| Costs And Expenses | $11.98B |
| Gross Profit | $9.09B |
| Nonoperating Income/Loss | -$897.00M |
| Operating Expenses | $7.48B |
| Depreciation and Amortization | $989.00M |
| Other Operating Expenses | $6.49B |
| Operating Income/Loss | $1.60B |
| Income/Loss Before Equity Method Investments | $708.00M |
| Income/Loss From Continuing Operations After Tax | $1.73B |
| Income/Loss From Continuing Operations Before Tax | $2.13B |
| Income/Loss From Equity Method Investments | $14.00M |
| Income Tax Expense/Benefit | $12.00M |
| Net Income/Loss | $709.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $2.00M |
| Net Income/Loss Attributable To Parent | $706.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $706.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.63 |
| Diluted Earnings Per Share | $0.60 |
| Basic Average Shares | 3,469,000,000 |
| Diluted Average Shares | 3,511,000,000 |
| Assets | $39.86B |
| Current Assets | $13.76B |
| Inventory | $3.22B |
| Prepaid Expenses | $1.03B |
| Other Current Assets | $9.51B |
| Noncurrent Assets | $26.10B |
| Fixed Assets | $3.93B |
| Other Non-current Assets | $22.17B |
| Liabilities | $32.10B |
| Current Liabilities | $15.65B |
| Wages | $488.00M |
| Other Current Liabilities | $15.16B |
| Noncurrent Liabilities | $16.45B |
| Equity | $7.76B |
| Equity Attributable To Noncontrolling Interest | $4.00M |
| Equity Attributable To Parent | $7.75B |
| Liabilities And Equity | $39.86B |
| Net Cash Flow From Operating Activities | $1.90B |
| Net Cash Flow From Operating Activities, Continuing | $1.90B |
| Net Cash Flow From Investing Activities | $38.00M |
| Net Cash Flow From Investing Activities, Continuing | $38.00M |
| Net Cash Flow From Financing Activities | -$401.00M |
| Net Cash Flow From Financing Activities, Continuing | -$401.00M |
| Exchange Gains/Losses | -$41.00M |
| Net Cash Flow | $1.49B |
| Net Cash Flow, Continuing | $1.54B |
| Comprehensive Income/Loss | $675.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $1.00M |
| Comprehensive Income/Loss Attributable To Parent | $674.00M |
| Other Comprehensive Income/Loss | -$34.00M |
| Other Comprehensive Income/Loss Attributable To Parent | -$34.00M |